Bangladesh’s International Centre for Diarrheal Disease Research Launches Phase II Ivermectin Clinical Trial

That Bangladesh could become a future hub of clinical research is palpable based on a number of unfolding trends.  TrialSite News discussed the nation of nearly 165 million—the 8th most populated in the world—with a dynamic and rapidly growing economy, innovative and...